TA
Tazeen Ahmad BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
Past Year
8.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Buy
56.3%
Hold
25%
Sell
18.8%
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
Scholar Rock
SRRK
$3.79B
|
Buy
Initiated
| $53 |
34%
upside
| 1 | +2% |
0
%
| 9 Oct ‘25 3 days ago |
|
Pharvaris
PHVS
$1.41B
|
Hold
Upgraded
| $27 |
23%
upside
| 1 | – |
–
| 9 Oct ‘25 3 days ago |
|
Alnylam Pharmaceuticals
ALNY
$60.4B
|
Buy
Maintained
| $520 |
13%
upside
| 1 | +15% |
0
%
| 17 Sep ‘25 25 days ago |
|
Incyte
INCY
$16.4B
|
Buy
Maintained
| $104 |
24%
upside
| 1 | +7.3% |
0
%
| 4 Sep ‘25 1 month ago |
|
Ascendis Pharma
ASND
$12.7B
|
Buy
Maintained
| $230 |
10%
upside
| 1 | +6.2% |
0
%
| 2 Sep ‘25 1 month ago |
|
argenx
ARGX
$49.1B
|
Buy
Maintained
| $887 |
11%
upside
| 1 | +12% |
0
%
| 2 Sep ‘25 1 month ago |
|
Sarepta Therapeutics
SRPT
$2.31B
|
Sell
Maintained
| $16 |
28%
downside
| 4 | -19% |
0
%
| 21 Aug ‘25 1 month ago |
|
PTC Therapeutics
PTCT
$5.26B
|
Buy
Maintained
| $76 |
15%
upside
| 2 | +17% |
0
%
| 20 Aug ‘25 1 month ago |
|
Acadia Pharmaceuticals
ACAD
$3.38B
|
Hold
Maintained
| $27 |
35%
upside
| 1 | – |
–
| 7 Aug ‘25 2 months ago |
|
BioNTech
BNTX
$24.5B
|
Buy
Maintained
| $134 |
31%
upside
| 2 | -3.9% |
0
%
| 5 Aug ‘25 2 months ago |
|
Apellis Pharmaceuticals
APLS
$3.17B
|
Hold
Maintained
| $24 |
4%
downside
| 1 | -37% |
0
%
| 16 Jul ‘25 2 months ago |
|